L'Oreal Scientists to Discuss How Their Integration of Nanotechnology in Cosmetics Works With Europe's 'Precautionary Principle'

BusinessWeek magazine claims the $60 billion international beauty products industry is "making a big bet on nanotech." Today, nearly a hundred cosmetics are in the Project on Emerging Nanotechnologies online inventory of products identified by manufacturers as containing nanomaterials.

Critical to the success of nanotechnology cosmetics is consumer confidence in their safety. In Europe, regulators and companies are attempting to apply "The Precautionary Principle" across all sectors.

How does a company like Paris-based cosmetics leader L'Oreal-which ranks No. 6 among nanotechnology patent holders in the U.S.- apply "The Precautionary Principle" to nanotechnology cosmetic products? What specific safety tests and post-market surveillance measures are used? How do U.S. and European regulations differ when applied to nanotechnology products? How does L'Oreal communicate with customers about this cutting-edge technology?

Scientists from L'Oreal will discuss these questions and more at a program on Thursday, June 5, 2008, in the auditorium of the Woodrow Wilson International Center for Scholars in Washington, DC.

*** Webcast LIVE at www.wilsoncenter.org***

What:              Small is Beautiful: A European View of Nanotechnology Cosmetics and Safety, from L'Oreal
Who:               Dr. Francis Quinn, L'Oreal, Dr. Andrew Maynard, Chief Science Advisor, Project on Emerging Nanotechnologies
When:             Thursday, June 5, 2008, 1:00 p.m. - 2:00 p.m. (A light lunch will be available from 12:15-12:45 p.m. in the 6th floor boardroom)|
Where:            Woodrow Wilson International Center for Scholars, 6th Floor Auditorium.  Ronald Reagan Building and International Trade Center, 1300 Pennsylvania Avenue, NW, Washington, DC 20004.

The Project on Emerging Nanotechnologies was launched in 2005 by the Wilson Center and The Pew Charitable Trusts. It is a partnership dedicated to helping business, governments, and the public anticipate and manage the possible health and environmental implications of nanotechnology.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.